Publications by authors named "R A Medina-Lopez"
Introduction: Renal cancer (RC) is not typically symptomatic until it reaches a considerable size and an advanced stage [World J Oncol. 2020;11(3):79-87]. The 5-year survival rate for metastatic renal cancer (mRC) is estimated at 13% [CA Cancer J Clin.
View Article and Find Full Text PDFArticle Synopsis
- There are many factors that help doctors understand how well patients with metastatic renal cell carcinoma (mRCC) might do, but some tools to help are not very perfect.
- A study looked at 78 patients to see how patient feelings and experiences might predict their survival better than just a doctor’s opinion.
- The results showed that a specific questionnaire (FKSI 19 score) could help tell how well patients may do, and it might work better than traditional methods used by doctors.
Objective: This study aimed to assess the influence of age, period, and cohort (A-P-C) factors on kidney cancer (KC) incidence trends in Spain from 1990 to 2019.
Methods: Employing data from the Global Burden of Disease Study 2019, we employed joinpoint analysis to determine long-term patterns and A-P-C modelling to quantify net drift, local drift, longitudinal age curves, and rate ratios (RRs) of period and cohort effects.
Results: Over the period 1990-2019, an estimated 142,811 cases of KC were diagnosed in Spain.